Dicerna Pharmaceuticals, Inc.
Therapeutic inhibition of lactate dehydrogenase and agents therefor

Last updated:

Abstract:

This invention relates to compounds, compositions, and methods useful for reducing lactact dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Status:
Grant
Type:

Utility

Filling date:

15 Mar 2019

Issue date:

11 Aug 2020